A 52-year-old man presents with a severe headache and widespread rash after a camping trip. What's your diagnosis?
Dermatology Times Staff
A Johns Hopkins study finds that physicians who use stigmatizing language in their patients' medical records, may actually be hurting the care those patients get for years to come.
In June, the European Commission approved tofacitinib citrate (Xeljanz/Pfizer) 5 mg twice daily in combination with methotrexate for adults with psoriatic arthritis. Learn about the parameters here.
Hawaii has the most overworked RN workforce, according to a report by Medicare Health Plann issued in June.
In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.
From the July issue of Dermatology Times, new products for dermatologists and patients.
The July issue of Dermatology Times highlights some newly approved treatments in dermatology including a new wrinkle filler and new treatment for seborrheic keratosis.
There are four questions physicians should ask when considering using digital healthcare technologies, says Michael L. Hodgkins, M.D., chief medical officer for the American Medical Association. View the slideshow for more information.
Diet can affect skin conditions including acne, atopic dermatitis, psoriasis and rosacea. In a review that focuses on these four conditions, plus aging, Rajani Katta, M.D., and Mary Jo Kramer, B.S., writing in Skin Therapy Letter, highlight trigger foods that should be avoided.